It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
It has been suggested that mitochondrial dysfunction and mtDNA variations may contribute to osteoarthritis (OA) pathogenesis. However, the causative link to support this claim is lacking. Here, we surgically-induced OA in conplastic mice in order to evaluate the functional consequences of mtDNA haplotypes in their joint degeneration. BL/6NZB strain was developed with C57BL/6JOlaHsd nuclear genome and NZB/OlaHsdmtDNA while BL/6C57, which is the original, was developed with C57BL/6JOlaHsd nuclear genome and C57/OlaHsdmtDNA for comparison. The surgical DMM OA model was induced in both strains. Their knees were processed and examined for histopathological changes. Cartilage expression of markers of autophagy, apoptosis, oxidative stress and senescence were also analyzed by immunohistochemistry. The joints of BL/6NZB mice that were operated presented more cellularity together with a reduced OARSI histopathology score, subchondral bone, menisci score and synovitis compared to those of BL/6C57 mice. This was accompanied with higher autophagy and a lower apoptosis in the cartilage of BL/6NZB mice that were operated. Therefore, the study demonstrates the functional impact of non-pathological variants of mtDNA on OA process using a surgically-induced OA model. Conplastic (BL/6NZB ) mice develop less severe OA compared to the BL/6C57original strain. These findings demonstrate that mitochondria and mtDNA are critical targets for potential novel therapeutic approaches to treat osteoarthritis.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade da Coruña (UDC), Grupo de Investigación de Reumatología (GIR), A Coruña, Spain (GRID:grid.488921.e)
2 Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain (GRID:grid.467824.b) (ISNI:0000 0001 0125 7682); CIBERES, Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); University of Oxford, Kennedy Institute of Rheumatology, Headington, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948)
3 Centro Tecnológico de Formación Xerencia de Xestión Integrada A Coruña (XXIAC), A Coruña, Spain (GRID:grid.4991.5)
4 Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain (GRID:grid.467824.b) (ISNI:0000 0001 0125 7682)
5 Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain (GRID:grid.467824.b) (ISNI:0000 0001 0125 7682); CIBERFES, Madrid, Spain (GRID:grid.467824.b)
6 Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas, Universidade da Coruña (UDC), Grupo de Investigación de Reumatología (GIR), A Coruña, Spain (GRID:grid.488921.e); Departamento de Fisioterapia, Medicina y Ciencias Biomédicas, Facultad de Fisioterapia, Campus de Oza, Universidade da Coruña (UDC), Grupo de Investigación de Reumatología y Salud (GIR-S), A Coruña, Spain (GRID:grid.8073.c) (ISNI:0000 0001 2176 8535)